LEADING EDGE BIO

In "Beyond business as usual: Disrupting the biopharma business model," a distinguished group of panelists discussed both the problems...

Four strategic recommendations for disruptive innovators in biopharma businesses are as follows: Partner aggressively to develop assets...

An innovative new cancer drug shown to extend the lives of women with breast cancer by an average of 6 months has recently crossed an...

The forces that lead to disruption are always at work in every industry. In every sizable company, the set of ideas that has been...